Cullinan Therapeutics, Inc. — All Filings
428 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001005 | Mar 26, 2026 | — |
| S-8 | S-8 | 0001193125-26-099373 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001193125-26-099362 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-099355 | Mar 10, 2026 | — |
| 4 | 4 | 0001193125-26-098781 | Mar 9, 2026 | Mar 5, 2026 |
| 144 | — | 0001950047-26-002270 | Mar 5, 2026 | — |
| SCHEDULE 13G | — | 0001907884-26-000005 | Mar 4, 2026 | — |
| 4 | 4 | 0001193125-26-077259 | Feb 26, 2026 | Feb 25, 2026 |
| 4 | 4 | 0001193125-26-072002 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | 4 | 0001193125-26-072001 | Feb 25, 2026 | Feb 24, 2026 |
| 4 | 4 | 0001193125-26-072000 | Feb 25, 2026 | Feb 24, 2026 |
| 4 | 4 | 0001193125-26-071997 | Feb 25, 2026 | Feb 24, 2026 |
| 144 | — | 0001950047-26-001779 | Feb 25, 2026 | — |
| 4 | 4 | 0001193125-26-064257 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064256 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064255 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064254 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064261 | Feb 23, 2026 | Feb 20, 2026 |
| 144 | — | 0001950047-26-001659 | Feb 23, 2026 | — |
| 144 | — | 0001950047-26-001588 | Feb 20, 2026 | — |
| 4 | 4 | 0001193125-26-059641 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059640 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059639 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059638 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059637 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059636 | Feb 19, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | — | 0000921895-26-000457 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-051700 | Feb 13, 2026 | Feb 12, 2026 |
| SCHEDULE 13G | — | 0000102909-26-000065 | Jan 30, 2026 | — |
| 4 | 4 | 0001193125-26-021225 | Jan 23, 2026 | Jan 22, 2026 |
| 144 | — | 0001950047-26-000636 | Jan 22, 2026 | — |
| 8-K | 8-K | 0001193125-26-006998 | Jan 8, 2026 | — |
| 4 | 4 | 0001193125-26-002687 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-25-335482 | Dec 29, 2025 | Dec 23, 2025 |
| 4 | 4 | 0001193125-25-328909 | Dec 22, 2025 | Dec 19, 2025 |
| 4 | 4 | 0001193125-25-327033 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | 4 | 0001193125-25-327030 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | 4 | 0001193125-25-327027 | Dec 19, 2025 | Dec 18, 2025 |
| 144 | — | 0001950047-25-010561 | Dec 19, 2025 | — |
| 4 | 4 | 0001193125-25-321122 | Dec 16, 2025 | Dec 12, 2025 |
| 144 | — | 0001950047-25-010308 | Dec 15, 2025 | — |
| 8-K | 8-K | 0001193125-25-310764 | Dec 8, 2025 | — |
| 4 | 4 | 0001193125-25-297549 | Nov 25, 2025 | Nov 24, 2025 |
| 144 | — | 0001950047-25-009279 | Nov 24, 2025 | — |
| 8-K | 8-K | 0001193125-25-291448 | Nov 21, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-112463 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004966 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193805-25-001585 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-268066 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-268041 | Nov 6, 2025 | — |